MedTrace Logo

Multiomic Analysis of Serum in Acute Period of Traumatic Brain Injury

NCT05867992 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-09-05

No results posted yet for this study

Summary

The goal of this experimental observation study is to figure out differently expressed biomarkers in serum in traumatic brain injury patients, compared with bone fracture patients. The main questions it aims to answer are:

1. Which proteins and metabolites are differently expressed in TBI patients' serum?
2. Which proteins or metabolites can serve as the new serum biomarkers for diagnosing TBI? Participants will be treated by routine treatments, and their serum samples will be collected in the emergency room.

Conditions

Interventions

OTHER

Type of trauma

Patients in case group have the severe traumatic brain injury, while patients in control group have the traumatic bone fracture without brain injury.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Junfeng Feng, Ph.D. · RenJi Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-05-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05867992 on ClinicalTrials.gov